REGISTERED NUMBER: 10844861 (England and Wales)

Unaudited Financial Statements for the Year Ended 30th June 2025

for

Carr Green Medical Limited

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

3,093

3,201

CURRENT ASSETS

Debtors

5

26,119

3,142

Investments

6

80,424

78,302

Cash at bank

59,158

79,608

165,701

161,052

CREDITORS

Amounts falling due within one year

7

5,553

20,294

NET CURRENT ASSETS

160,148

140,758

TOTAL ASSETS LESS CURRENT LIABILITIES

163,241

143,959

PROVISIONS FOR LIABILITIES

588

608

NET ASSETS

162,653

143,351

CAPITAL AND RESERVES

Called up share capital

8

200

200

Retained earnings

162,453

143,151

SHAREHOLDERS' FUNDS

162,653

143,351

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14th October 2025 and were signed on its behalf by:

Professor B J Parker - Director

1.	COMPANY INFORMATION

Carr Green Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

10844861

Registered office:

The Lexicon

Mount Street

Manchester

M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers - 25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1st July 2024

1,441

6,237

7,678

Additions

-

1,099

1,099

At 30th June 2025

1,441

7,336

8,777

DEPRECIATION

At 1st July 2024

210

4,267

4,477

Charge for year

360

847

1,207

At 30th June 2025

570

5,114

5,684

NET BOOK VALUE

At 30th June 2025

871

2,222

3,093

At 30th June 2024

1,231

1,970

3,201

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

£

Trade debtors

2,802

3,142

Directors' current accounts

23,317

-

26,119

3,142

6.	CURRENT ASSET INVESTMENTS

30.6.25

30.6.24

£

£

Other

80,424

78,302

Market value of listed investments at 30 June 2025 - £80,424 (2024 - £78,302). The current asset investments represents holdings in listed shares. The listed shares are recognised at market value.

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

£

Tax

4,535

8,296

Directors' current accounts

-

11,041

Accrued expenses

1,018

957

5,553

20,294

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.6.25

30.6.24

value:

£

£

100

Ordinary A

1

100

100

100

Ordinary B

1

100

100

200

200

The ordinary A shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B shares rank pari passu in respect of dividend and capital distribution rights.

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30th June 2025 and 30th June 2024:

30.6.25

30.6.24

£

£

Professor B J Parker and Dr G Parker

Balance outstanding at start of year

(11,041

)

(4,729

)

Amounts advanced

35,670

4,000

Amounts repaid

(1,312

)

(10,312

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

23,317

(11,041

)

The loan is repayable on demand and no interest was charged during the year.

10.

CONTROL